| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology and Toxicology and Division of Oncology, University of Rochester School of Medicine, Rochester, New York 14620
The antineoplastic alkaloid camptothecin inhibits nucleic acid synthesis in leukemia L1210 cells; this inhibition is initially reversible, but becomes irreversible when exposure to the drug is prolonged. A drug-resistant subline, L1210/CN, can overcome camptothecin-induced inhibition of nucleic acid biosynthesis before this becomes irreversible. Unlike actinomycin D-resistant cell lines, L1210/CN was not characterized by a drug permeability barrier nor by altered levels of cell surface glycoprotein.
1 Supported by Grants CA-11198 and CA-11242 from NIH, a grant from the Monroe County Cancer and Leukemia Society, and institutional (General Research Support Grant) funds.
Received 5/ 3/71. Accepted 7/13/71.
This article has been cited by other articles:
![]() |
S. Ohdo, T. Makinosumi, T. Ishizaki, E. Yukawa, S. Higuchi, S. Nakano, and N. Ogawa Cell Cycle-Dependent Chronotoxicity of Irinotecan Hydrochloride in Mice J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1383 - 1388. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |